Vimarsana
Biggest News Aggregation in the World

Page 2 - Process Performance Qualification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Process Performance Qualification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Process Performance Qualification Today - Breaking & Trending Today

Preparing for the Next Pandemic - Vimarsana News

Preparing for the Next Pandemic

WuXi Vaccines offers a CDMO's perspective on meeting the global vaccine supply challenge.

Preparing for the Next Pandemic - Vimarsana News

Preparing for the Next Pandemic

WuXi Vaccines offers a CDMO's perspective on meeting the global vaccine supply challenge.

Pfizer's COVID vaccine factory: Witnessing a modern miracle - Vimarsana News

Pfizer's COVID vaccine factory: Witnessing a modern miracle

Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.

Source: jpost.com
GenSight GT delay due to CDMO issue - BioProcess Insider - Vimarsana News

GenSight GT delay due to CDMO issue - BioProcess Insider

GenSight Biologics pushed back regulatory dates because of an operational issue at CDMO Brammer Bio, a subsidiary of Thermo Fisher.

GenSight Biologics S.A.: GenSight Biologics Provides Update on LUMEVOQ Manufacturing and Commercialization Timelines - Vimarsana News

GenSight Biologics S.A.: GenSight Biologics Provides Update on LUMEVOQ Manufacturing and Commercialization Timelines

PPQ campaign to start early May 2023 (previously end of March) with results expected in Q3 2023 EMA CHMP opinion now expected in Q1 2024 (previously September 2023) Regulatory News: GenSight